<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Baydakova GV</submitter><funding>The Ministry of Science and Higher Education of the Russian Federation</funding><funding>The Ministry of Science and Higher Education of the Russian Federation (the Federal Scientific-technical program for genetic technologies development for 2019-2027)</funding><pagination>48</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10531771</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(3)</volume><pubmed_abstract>Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (MTP) deficiencies are rare fatal disorders of fatty acid β-oxidation with no apparent genotype-phenotype correlation. The measurement of acylcarnitines by MS/MS is a current diagnostic workup in these disorders. Nevertheless, false-positive and false-negative results have been reported, highlighting a necessity for more sensitive and specific biomarkers. This study included 54 patients with LCHAD/MTP deficiency that has been confirmed by biochemical and molecular methods. The analysis of acylcarnitines in dried blood spots was performed using ESI-MS/MS. The established "HADHA ratio" = (C16OH + C18OH + C18:1OH)/C0 was significantly elevated in all 54 affected individuals in comparison to the control </pubmed_abstract><journal>International journal of neonatal screening</journal><pubmed_title>New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.</pubmed_title><pmcid>PMC10531771</pmcid><funding_grant_id>Agreement N 075-15-2021-1061, RF 193021X0029</funding_grant_id><funding_grant_id>RF 193021X0029</funding_grant_id><funding_grant_id>N 075-15-2021-1061</funding_grant_id><pubmed_authors>Baydakova GV</pubmed_authors><pubmed_authors>Tsygankova PG</pubmed_authors><pubmed_authors>Bazhanova OA</pubmed_authors><pubmed_authors>Zakharova EY</pubmed_authors><pubmed_authors>Nazarenko YD</pubmed_authors><pubmed_authors>Pechatnikova NL</pubmed_authors></additional><is_claimable>false</is_claimable><name>New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.</name><description>Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (MTP) deficiencies are rare fatal disorders of fatty acid β-oxidation with no apparent genotype-phenotype correlation. The measurement of acylcarnitines by MS/MS is a current diagnostic workup in these disorders. Nevertheless, false-positive and false-negative results have been reported, highlighting a necessity for more sensitive and specific biomarkers. This study included 54 patients with LCHAD/MTP deficiency that has been confirmed by biochemical and molecular methods. The analysis of acylcarnitines in dried blood spots was performed using ESI-MS/MS. The established "HADHA ratio" = (C16OH + C18OH + C18:1OH)/C0 was significantly elevated in all 54 affected individuals in comparison to the control </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2026-05-14T03:10:22.646Z</modification><creation>2025-02-19T00:11:19.89Z</creation></dates><accession>S-EPMC10531771</accession><cross_references><pubmed>37754774</pubmed><doi>10.3390/ijns9030048</doi></cross_references></HashMap>